Ayahuasca: what mental health professionals need to know
Rafael G. Dos Santos, José Carlos Bouso, Jaime E. C. Hallak
Archives of Clinical Psychiatry (São Paulo) August 1, 2017 DOI: 10.1590/0101-60830000000130 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Narrative review Randomized Open-label Peer reviewed |
|---|---|
| Intervention | Ayahuasca |
| Topics | Ayahuasca |
| Keywords | Adverse effect |
| Citations | 15 |
| Key findings | Ayahuasca in controlled settings appears safe and may have therapeutic effects for treatment-resistant psychiatric disorders, though prolonged psychotic reactions can occur in susceptible individuals. |
Abstract
Abstract Background Ayahuasca is a psychoactive ethnobotanical concoction that has been used for decades by indigenous groups of the Northwestern Amazon and by syncretic religious organizations for ritual and therapeutic purposes. In the last two decades, it is being used worldwide in evolving practices. Ayahuasca seem to therapeutic effects, but controlled studies are lacking. Moreover, its safety and toxicity are not completely understood.
Objectives: To present an overview of the effects of ayahuasca based on the most recent human studies.
Methods: Narrative review.
Results: Ayahuasca administration in controlled settings appears to be safe from a subjective and physiological perspective, with few adverse reactions being reported. More frequent adverse reactions occur in non-controlled settings. Prolonged psychotic reactions are rare and seem to occur especially in susceptible individuals. Ayahuasca showed antidepressive, anxiolytic, and antiaddictive effects in animal models, observational studies, and in open-label and controlled studies.
Discussion: Ayahuasca administration in controlled settings appear to be safe. Moreover, ayahuasca seem to have therapeutic effects for treatment-resistant psychiatric disorders that should be further investigated in randomized controlled clinical trials. However, medical complications and cases of prolonged psychotic reactions have been reported, and people with personal or family history of psychotic disorders should avoid ayahuasca intake.
Comparable studies
Other narrative reviews on ayahuasca, most cited first.
Citations in the library
Cited by 10
- Ayahuasca, an ancient substance with traditional and contemporary use in neuropsychiatry and neuroscience Epilepsy & Behavior June 7, 2019
- Ayahuasca's therapeutic potential: What we know - and what not. European Neuropsychopharmacology 2023
- The influence of ceremonial settings on mystical and challenging experiences occasioned by ayahuasca: A survey among ritualistic and religious ayahuasca users Frontiers in Psychology July 15, 2022
- The current state of ayahuasca research in animal models: A systematic review. Progress in Neuro-Psychopharmacology and Biological Psychiatry July 13, 2023
- Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic Scientific Reports September 11, 2023
and 5 more in the library
Cites 66
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
- Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action Neuroreport December 1, 1998
and 61 more in the library